Clinical Trials
18 trialsNCT03598257 2026-05-13
Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT00016549 2017-07-02
Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00070252 2015-05-04
Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00002627 2014-01-10
Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00003679 2013-11-06
Combination Chemotherapy in Treating Women With Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003680 2013-11-06
Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00005058 2013-11-06
Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer
National Cancer Institute (NCI)
Phase NA Unknown
NCT00002616 2013-09-20
Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00094133 2013-09-20
Hypnosis in Treating Hot Flashes in Breast Cancer Survivors
National Cancer Institute (NCI)
Phase NA Unknown
NCT00336089 2013-09-17
Exercise Program or Health Education Program in Reducing Fatigue and Pain in Breast Cancer Survivors
National Cancer Institute (NCI)
Phase NA Unknown
NCT00288002 2013-08-26
Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00310089 2013-06-20
AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer
National Cancer Institute (NCI)
Phase NA Completed
NCT00049114 2013-06-06
Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00004074 2013-02-28
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
National Cancer Institute (NCI)
Phase 1 Completed
NCT00005842 2013-02-11
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00016276 2013-01-16
Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 3 Terminated
NCT00398489 2010-11-09
Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01093235 2010-03-25
Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown